SCHEMBL982401

SCHEMBL982401

O=C(Cc1ccc(F)cc1)N1CCC(c2cccs2)=N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.46
KMT2A Q03164 6/20 0.46
GAA P10253 3/20 0.46
LMNA P02545 2/20 0.46
KDM4E B2RXH2 9/20 0.46
MAPT P10636 4/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
MEN1 O00255 3/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
GLA P06280 2/20 0.42
MAPK1 P28482 2/20 0.42
ATM Q13315 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
RXFP1 Q9HBX9 1/20 0.42
PKM P14618 1/20 0.42
YAP1 P46937 1/20 0.41
TEAD4 Q15561 1/20 0.41
POLB P06746 2/20 0.41
HPGD P15428 3/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17004399 0.89 ALDH1A1 (0.49) ALDH1A1KMT2AGAALMNAKDM4E
SCHEMBL982035 0.85 ALDH1A1 (0.53) ALDH1A1KMT2AGAALMNAKDM4E
SCHEMBL982034 0.83 ALDH1A1 (0.50) ALDH1A1KMT2AGAALMNAKDM4E
SCHEMBL980870 0.81 MAOB (0.53) ALDH1A1KMT2AMAPTMEN1SMN1; SMN2
SCHEMBL982599 0.80 MEN1 (0.47) ALDH1A1KMT2ALMNAMAPTMEN1
SCHEMBL981784 0.79 ALDH1A1 (0.49) ALDH1A1KMT2ALMNAKDM4EMAPT
SCHEMBL981914 0.78 POLB (0.42) ALDH1A1KMT2AGAALMNAMAPT
SCHEMBL12922889 0.78 MAOB (0.50) ALDH1A1LMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL981737 0.77 ME2 (0.51) ALDH1A1KMT2AMAPTMEN1SMN1; SMN2
SCHEMBL981923 0.76 POLB (0.41) ALDH1A1KDM4EMAPTL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP claimed
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MERCK PATENT GESELLSCHAFT (DE) 2008-10-09 US claimed
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MET, FLT3, ERBB3 ALDH1A1 399/4885KMT2A 174/4885GAA 2975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.